These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29173689)

  • 1. Esophageal abnormalities in juvenile localized scleroderma: is it associated with other extracutaneous manifestations?
    Valões CCM; Novak GV; Brunelli JB; Kozu KT; Toma RK; Silva CA
    Rev Bras Reumatol Engl Ed; 2017; 57(6):521-525. PubMed ID: 29173689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study.
    Zulian F; Athreya BH; Laxer R; Nelson AM; Feitosa de Oliveira SK; Punaro MG; Cuttica R; Higgins GC; Van Suijlekom-Smit LW; Moore TL; Lindsley C; Garcia-Consuegra J; Esteves Hilário MO; Lepore L; Silva CA; Machado C; Garay SM; Uziel Y; Martini G; Foeldvari I; Peserico A; Woo P; Harper J;
    Rheumatology (Oxford); 2006 May; 45(5):614-20. PubMed ID: 16368732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of Juvenile localized scleroderma and its management.
    Li SC; Zheng RJ
    World J Pediatr; 2020 Feb; 16(1):5-18. PubMed ID: 31786801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localized scleroderma in childhood is not just a skin disease.
    Zulian F; Vallongo C; Woo P; Russo R; Ruperto N; Harper J; Espada G; Corona F; Mukamel M; Vesely R; Musiej-Nowakowska E; Chaitow J; Ros J; Apaz MT; Gerloni V; Mazur-Zielinska H; Nielsen S; Ullman S; Horneff G; Wouters C; Martini G; Cimaz R; Laxer R; Athreya BH;
    Arthritis Rheum; 2005 Sep; 52(9):2873-81. PubMed ID: 16142730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophageal involvement in juvenile localized scleroderma: a pilot study.
    Guariso G; Conte S; Galeazzi F; Vettorato MG; Martini G; Zulian F
    Clin Exp Rheumatol; 2007; 25(5):786-9. PubMed ID: 18078634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile localized scleroderma: A single-centre experience from India.
    Jindal AK; Handa S; Loganathan SK; Sudhakar M; Kaushik A; Suri D; Pandiarajan V; Rawat A; Gupta A; De D; Mahajan R; Singh S
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):598-604. PubMed ID: 36413107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.
    Arif T; Masood Q; Singh J; Hassan I
    BMC Gastroenterol; 2015 Feb; 15():24. PubMed ID: 25888470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.
    Lythgoe H; Almeida B; Bennett J; Bhat C; Bilkhu A; Brennan M; Deepak S; Dawson P; Eleftheriou D; Harrison K; Hawley D; Heaf E; Leone V; Long E; Maltby S; McErlane F; Rafiq N; Ramanan AV; Riley P; Rangaraj S; Varnier G; Wilkinson N; Pain CE
    Pediatr Rheumatol Online J; 2018 Dec; 16(1):80. PubMed ID: 30563543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes.
    Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE
    J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracutaneous involvement is common and associated with prolonged disease activity and greater impact in juvenile localized scleroderma.
    Li SC; Higgins GC; Chen M; Torok KS; Rabinovich CE; Stewart K; Laxer RM; Pope E; Haines KA; Punaro M; O'Neil KM;
    Rheumatology (Oxford); 2021 Dec; 60(12):5724-5733. PubMed ID: 33711155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connective tissue nevus misdiagnosed as juvenile localized scleroderma.
    Tirelli F; Giraudo C; Soliani M; Calabrese F; Martini G; Gisondi P; Meneghel A; Zulian F
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):125. PubMed ID: 37848914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital localized scleroderma.
    Zulian F; Vallongo C; de Oliveira SK; Punaro MG; Ros J; Mazur-Zielinska H; Galea P; Da Dalt L; Eichenfield LF
    J Pediatr; 2006 Aug; 149(2):248-51. PubMed ID: 16887444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of family impact of juvenile localized scleroderma.
    Milovanova K; Adly M; Lethebe BC; Stevenson R; Prajapati VH; Luca NJC
    Pediatr Dermatol; 2021 Sep; 38(5):1137-1142. PubMed ID: 34263473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular involvement in children with localised scleroderma: a multi-centre study.
    Zannin ME; Martini G; Athreya BH; Russo R; Higgins G; Vittadello F; Alpigiani MG; Alessio M; Paradisi M; Woo P; Zulian F;
    Br J Ophthalmol; 2007 Oct; 91(10):1311-4. PubMed ID: 17475707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate in Linear Scleroderma: Long-Term Efficacy in Fifty Children From a Single Pediatric Rheumatology Center.
    Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F; Martini G
    Arthritis Care Res (Hoboken); 2021 Sep; 73(9):1259-1263. PubMed ID: 32433808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic Review of Health-Related Quality of Life Impact in Juvenile Localized Scleroderma.
    Sanchez-Espino LF; Luca N; Pope E; Laxer RM; Knight AM; Sibbald C
    Arthritis Care Res (Hoboken); 2024 Mar; 76(3):340-349. PubMed ID: 37750181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences.
    Lis-Święty A; Skrzypek-Salamon A; Ranosz-Janicka I; Brzezińska-Wcisło L
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1595-1603. PubMed ID: 28271552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.